When Pfizer bought Wyeth last year, the company said that it expected to cut about 15 percent of its workforce. However, on Friday, Pfizer said in a filing with the US Securities and Exchange Commission that the company will likely exceed that percentage, reports the Wall Street Journal. "At this point, it's too early to determine the extent to which we will exceed this target," says Joan Campion, a company spokesperson. The Journal adds that Pfizer appears to have nearly reached its original goal of a 15 percent reduction, noting that in January 2009 Pfizer and Wyeth had a combined 129,500 employees, and as of October there were only 111,500, "implying that 18,000 jobs have already been cut from January 2009 levels, or a nearly 14 percent reduction."
HT: Pharmalot